Inflammation associated with obesity: Relationship with blood and bone marrow endothelial cells

Obesity

Volumn 19, Issue 11, 2011, Pages 2130-2136

  McGuire, Timothy R ^a   Brusnahan, Susan K ^a   Bilek, Laura D ^b   Jackson, John D ^a   Kessinger, M Anne ^c   Berger, Anne M ^b   Garvin, Kevin L ^b   O'Kane, Barbara J ^b   Tuljapurkar, Sonal R ^b   Sharp, John G ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; INTERLEUKIN 10; SOMATOMEDIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BODY MASS; BONE MARROW CELL; CELL POPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BONE MARROW; BONE MARROW CELLS; C-REACTIVE PROTEIN; ENDOTHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; SOMATOMEDINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80055034383     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.246     Document Type: Article

References (37)

1. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97.
2. Finch CE. The Biology of Human Longevity: Inflammation, Nutrition, and Aging in the Evolution of Lifespans. Elsevier: Burlington, MA, 2007.
3. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 2010;6: 71-82.
4. Libby P. How our growing understanding of inflammation has reshaped the way we think of disease and drug development. Clin Pharmacol Ther 2010;87:389-391.
5. Greenfield JR, Samaras K, Jenkins AB et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004;109:3022-3028. (Pubitemid 38808325)
6. Roytblat L, Rachinsky M, Fisher A et al. Raised interleukin-6 levels in obese patients. Obes Res 2000;8:673-675.
7. Straczkowski M, Dzienis-Straczkowska S, Stêpieñ A et al. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002;87:4602-4606. (Pubitemid 35247047)
8. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638. (Pubitemid 36459468)
9. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-2698. (Pubitemid 34615135)
10. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003;55:241-269.
11. Frystyk J, Brick DJ, Gerweck AV et al. Bioactive IGF-1 in obesity. Endocrinol 2009;150:3433-3434.
12. Ridker PM, Danielson E, Fonseca FA et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
13. Charwat S, Gyöngyösi M, Lang I et al. Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol 2008;36:672-680.
14. Müller-Ehmsen J, Braun D, Schneider T et al. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur Heart J 2008;29:1560-1568. (Pubitemid 351881989)
15. MacEneaney OJ, Kushner EJ, Van Guilder GP et al. Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. Int J Obes (Lond) 2009;33:219-225.
16. Sata M, Fukuda D, Tanaka K et al. The role of circulating precursors in vascular repair and lesion formation. J Cell Mol Med 2005;9:557-568. (Pubitemid 44151947)
17. Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 2008;99:1501-1506.
18. van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569-2578.
19. Georgiou HD, Namdarian B, Corcoran NM, Costello AJ, Hovens CM. Circulating endothelial cells as biomarkers of prostate cancer. Nat Clin Pract Urol 2008;5:445-454.
20. Rigolin GM, Maffei R, Rizzotto L et al. Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. Cancer 2010;116:1926-1937.
21. Tobler K, Freudenthaler A, Baumgartner-Parzer SM et al. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond) 2010;34:687-700.
22. Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 2011;50:266-272.
23. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost 2009;7 Suppl 1:49-52.
24. Garvin K, Feschuk C, Sharp JG, Berger A. Does the number or quality of pluripotent bone marrow stem cells decrease with age? Clin Orthop Relat Res 2007;465:202-207. (Pubitemid 350306517)
25. Yoder MC, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809. (Pubitemid 46348173)
26. Case J, Mead LE, Bessler WK et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-1118. (Pubitemid 46921310)
27. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006;98:e20-e25.
28. Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett 2006;236:13-23. (Pubitemid 44382538)
29. Das W. Is obesity an inflammatory condition? Nutrition 2001;17:953-966.
30. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006;113:1141-1147. (Pubitemid 44401207)
31. Sopasakis VR, Sandqvist M, Gustafson B et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004;12:454-460. (Pubitemid 41132524)
32. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-1013. (Pubitemid 46525079)
33. Verma S, Kuliszewski MA, Li SH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004;109:2058-2067. (Pubitemid 38620212)
34. Zhang Y, Ingram DA, Murphy MP et al. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2009;296:H1675-H1682.
35. Heida NM, Müller JP, Cheng IF et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 2010;55:357-367.
36. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945-1956. (Pubitemid 39473277)
37. Margolis KL, Manson JE, Greenland P et al.; Women's Health Initiative Research Group. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-508. (Pubitemid 40344380)